Show Cart

News Channels

07 Sep 2018 FDA Approves Grifols New GamaSTAN® (immune globulin [human]) to Treat Patients Exposed to Hepatitis A and Measles
06 Sep 2018 Advicenne Announces FDA Clearance of IND to Commence Pivotal Phase 3 Trial of ADV7103 for Distal Renal Tubular Acidosis
06 Sep 2018 MabSpace Biosciences Doses First Patient in China Phase 1 Trial for MSB2311 and Submitted IND for MSB0254 to NMPA
06 Sep 2018 Vertex Completes Enrollment of Two Phase 3 Studies of VX-659 in Triple Combination with Tezacaftor and Ivacaftor for the Treatment of Cystic Fibrosis
06 Sep 2018 PvP Biologics Announces First-in-Human Clinical Trials for a Novel Therapeutic for Celiac Disease
06 Sep 2018 Neumentum Announces Dosing of Patients in Phase I Study Evaluating Its Lead Product Candidate, NTM-001, a Non-Opioid in Development for the Management of Moderately Severe Acute Pain
06 Sep 2018 Lilly Announces Positive Phase 3 Results in Study of Flortaucipir PET Imaging Agent
06 Sep 2018 Merrimack Completes Enrollment in Randomized Phase 2 SHERLOC Study of MM-121 (seribantumab) in Non-Small Cell Lung Cancer (NSCLC)
06 Sep 2018 argenx doses first patient in global Phase 3 registration trial of efgartigimod for the treatment of generalized myasthenia gravis
06 Sep 2018 Gilead and Galapagos announce TORTUGA phase 2 study of filgotinib in ankylosing spondylitis achieves primary endpoint
06 Sep 2018 Xenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a “Phase 3 Ready” Potassium Channel Modulator for the Treatment of Epilepsy
06 Sep 2018 Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101
06 Sep 2018 Atara Biotherapeutics and Moffitt Cancer Center Announce Strategic Collaboration to Develop Next-Generation CAR T Immunotherapies
06 Sep 2018 ContraFect Completes Enrollment in Phase 2 Clinical Trial Evaluating CF-301 (exebacase) in Patients with Staphylococcus Aureus Bacteremia
06 Sep 2018 Checkmate Pharmaceuticals Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate Combination Therapy with CMP-001 and Avelumab
06 Sep 2018 Eureka Therapeutics Achieves Regression of Metastatic Liver Cancer using ET140202 T-cell Therapy
05 Sep 2018 Loxo Oncology Announces Receipt of Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-292
05 Sep 2018 Poseida Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed/Refractory Multiple Myeloma
05 Sep 2018 Biothera Pharmaceuticals Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca
05 Sep 2018 Inovio Doses 1st Subject in Phase 1/2 Clinical Trial For Vaccine Against Deadly MERS Infection

Currencies

Shopping cart

Cart empty

Latest report

Featured Products

Latest Target Pipeline

Currencies

Shopping cart

Cart empty

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top